Cardinal Health Exceeds Q1 Fiscal 2027 Expectations and Raises Full-Year Guidance
Cardinal Health (CAH) reported strong first-quarter fiscal 2027 results, surpassing analyst expectations for both revenue and adjusted earnings per share. Revenue reached $67.51 billion, a 4% year-over-year increase, while adjusted EPS rose 28% to $3.26, significantly beating the consensus estimate of $2.94. The company's Pharmaceutical and Specialty Solutions segment drove much of this success, benefiting from high demand for generic medications and specialty therapeutics in oncology and urology. Following the beat, Cardinal Health raised its full-year adjusted EPS guidance, signaling management confidence in continued growth. While the 'Other' segment missed revenue and profit targets, the overall performance positioned the company as a strong defensive play amid market volatility and rotation away from AI-driven tech stocks. The company also highlighted long-term growth potential through its managed services organizations (MSOs) and future M&A opportunities.
Topics: earnings beat guidance raise healthcare distribution revenue growth
Part of the story Cardinal Health Reports Strong Q1 Fiscal 2027 Results and Raises Annual EPS Guidance (27 articles)